Therapeutic potential of cholecystokinin receptor antagonists in CNS disorders.
Schiantarelli
P
P
Preclinical Research Division, Boehringer Ingelheim Italy, Milano.
D000818:Animals; D001570:Benzodiazepinones; D001921:Brain / Q000187:drug effects; D001927:Brain Diseases / Q000188:drug therapy*; D002766:Cholecystokinin / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D020109:Devazepide; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*
D001570:Benzodiazepinones; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin; D020109:Devazepide; D004298:Dopamine